Vimarsana
Biggest News Aggregation in the World

Page 13 - Sosei Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sosei Group Today - Breaking & Trending Today

Sosei Heptares to present at 40th Annual J.P. Morgan Healthcare Conference - Vimarsana News

Sosei Heptares to present at 40th Annual J.P. Morgan Healthcare Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences - Vimarsana News

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences

24.12.2021 - TOKYO, Japan and CAMBRIDGE, United Kingdom, Dec. 23, 2021 (GLOBE NEWSWIRE) - Sosei Group Corporation (“Sosei Heptares”; TSE: 4565) today announces that in connection with the Collaboration and License Agreement (“License Agreement”) with ...

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences - Vimarsana News

Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies Against GPCR Targets - Vimarsana News

Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies Against GPCR Targets

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Sosei Heptares Receives Grant Funding from Wellcome to Advance the Development of Potent, Differentiated Oral Anti-Viral Small Molecules to Treat COVID-19 - Vimarsana News

Sosei Heptares Receives Grant Funding from Wellcome to Advance the Development of Potent, Differentiated Oral Anti-Viral Small Molecules to Treat COVID-19

Funding comes through the Covid-19 Therapeutics Accelerator, which was set up by Wellcome, Bill & Melinda Gates Foundation and Mastercard TOKYO and CAMBRIDGE, United Kingdom, Dec. 7, 2021